The power of GLP-1s
Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 that is released by the gut after eating.
Participants using GLP-1 medication lost 5 times more weight than with diet & exercise alone¹
¹ 68 week clinical trial of weekly Semaglutide injection (Wegovy) with 1,961 participants.